Study guide
12.3 Home Medical Devices and Device Technique Coaching
PEBC Pharmacist Evaluating Examination Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & The Canadian Pharmacy Practice Landscape
1.1 PEBC EE Blueprint, Format, Scoring, and IPG Certification Pathway 1.2 The Canadian Healthcare System, Canada Health Act, and Drug Regulation 1.3 Canadian Pharmacy Regulatory Framework, NAPRA Standards, and Professional Legislation
2 Chapter 2: Pharmaceutics & Drug Delivery Systems
2.1 Physicochemical Principles, Solubility, Ionization, and Stability 2.2 Solid Dosage Forms, Formulation Science, and Modified-Release Technologies 2.3 Liquid and Semisolid Dosage Forms, Dispersions, and Topical Delivery 2.4 Sterile Product Principles, Parenteral Delivery, and Biopharmaceuticals 2.5 Pharmaceutical Quality: GMP, Stability Testing, and Bioequivalence
3 Chapter 3: Biopharmaceutics & Clinical Pharmacokinetics
3.1 Drug Absorption, Distribution, Metabolism, and Elimination (ADME) 3.2 Bioavailability, Bioequivalence, and Biopharmaceutics Classification System (BCS) 3.3 Pharmacokinetic Modeling, Parameters, and Dosing Calculations 3.4 Therapeutic Drug Monitoring (TDM) and Clinical Application
4 Chapter 4: Pharmacology, Toxicology & Pharmacogenetics
4.1 Autonomic and Central Nervous System Pharmacology 4.2 Cardiovascular, Renal, and Endocrine Pharmacology 4.3 Clinical Toxicology, Overdose Management, and Antidotes 4.4 Biologics, Biosimilars, and Pharmacogenetics
5 Chapter 5: Pathophysiology & Clinical Assessment
5.1 Clinical Laboratory Diagnostics, Biomarkers, and Vital Signs 5.2 Cardiovascular and Respiratory Pathophysiology 5.3 Endocrine, Renal, and Gastrointestinal Pathophysiology 5.4 Neurologic, Psychiatric, and Musculoskeletal Pathophysiology 5.5 Physical Assessment and Point-of-Care Testing
6 Chapter 6: Pharmacotherapy & Minor Ailments
6.1 Cardiovascular Pharmacotherapy & Evidence-Based Guidelines 6.2 Endocrine and Metabolic Pharmacotherapy 6.3 Infectious Diseases and Antimicrobial Stewardship 6.4 Neurologic, Psychiatric, and Pain Management Therapeutics 6.5 Minor Ailment Prescribing and Nonprescription Therapy 6.6 Respiratory Pharmacotherapy: Asthma, COPD, and Inhaled Therapy 6.7 Gastrointestinal and Hepatic Pharmacotherapy 6.8 Renal, Fluid, and Electrolyte Therapeutics 6.9 Musculoskeletal and Rheumatologic Pharmacotherapy 6.10 Dermatologic, Ophthalmic, and Ear-Nose-Throat Pharmacotherapy 6.11 Hematologic, Immunologic, and Oncology Supportive Care 6.12 Women's Health, Men's Health, and Urologic Therapeutics 6.13 Nutrition, Natural Health Products, and Complementary Medicine
7 Chapter 7: Special Populations & Applied Therapeutics
7.1 Geriatric Pharmacotherapy and Deprescribing 7.2 Pediatric and Neonatal Pharmacotherapy 7.3 Perinatal Pharmacotherapy: Pregnancy and Lactation 7.4 Dosage Adjustments in Renal and Hepatic Impairment
8 Chapter 8: Prescription Processing, Calculations & Compounding
8.1 Prescription Processing, Verification, and Drug Therapy Problem Management 8.2 Pharmaceutical Calculations and Clinical Math 8.3 Non-Sterile Compounding and NAPRA Standards 8.4 Sterile and Hazardous Compounding under NAPRA Standards 8.5 Advanced Calculations: Infusion Rates, Parenteral Nutrition, and Renal Estimation
9 Chapter 9: Health Equity, Indigenous Health & Pharmacy Bioethics
9.1 Social Determinants of Health and Health Equity 9.2 Indigenous Health, Cultural Safety, and Humility 9.3 Pharmacy Bioethics, Informed Consent, and Professional Boundaries 9.4 Health Promotion, Disease Prevention, and Public Health
10 Chapter 10: Evidence Appraisal, Safety & Practice Management
10.1 Biostatistics and Critical Appraisal of Clinical Literature 10.2 Pharmacoeconomics and Pharmacoepidemiology 10.3 Medication Safety, Incident Analysis, and Quality Improvement 10.4 Pharmacy Operations, Cold-Chain Management, and Emergency Preparedness 10.5 Drug Information and Evidence-Based Decision Making 10.6 Pharmacovigilance and Adverse Drug Reaction Reporting in Canada
11 Chapter 11: Patient Care Process, Communication & Collaborative Practice
11.1 The Patient Care Process: Assessment, Care Plans, and Follow-Up 11.2 Patient and Caregiver Communication, Education, and Health Literacy 11.3 Motivational Interviewing and Shared Decision-Making 11.4 Intra- and Interprofessional Collaborative Care
12 Chapter 12: Medication Administration, Devices & Expanded Scope
12.1 Injection and Vaccine Administration Technique 12.2 Immunization Schedules, Vaccine Selection, and Travel Health 12.3 Home Medical Devices and Device Technique Coaching 12.4 Expanded Scope: Adapting, Renewing, Initiating, and Medication Reconciliation
13 Chapter 13: Pharmacy Management, Finance & Practice Leadership
13.1 Human Resources, Leadership, and Change Management 13.2 Financial Management, Drug Plans, and Marketing 13.3 Quality Improvement, Risk Management, and Workplace Safety
12.3 Home Medical Devices and Device Technique Coaching
Key Takeaways Explain This Topic AI
Home blood pressure measurement requires 5 minutes of rest, back supported, feet flat, arm at heart level, and a correctly sized cuff whose bladder encircles at least 80% of the arm.
Blood glucose meters must be checked for strip lot coding, expiry, and adequate sample size, and the first drop is wiped away when hands cannot be washed.
Insulin pens require a 5 to 6 second hold after the plunger bottoms out, a new needle for every injection, and site rotation to prevent lipohypertrophy.
Peak flow measurement is performed standing with three forced efforts, and the best of the three is recorded against personal best rather than predicted values.
A blood pressure cuff that is too small overestimates blood pressure and can lead to unnecessary treatment.
Last updated: August 2026
12.3 Home Medical Devices and Device Technique Coaching
Exam Focus: "Home medical devices" is an explicit syllabus bullet under prescription processing, product preparation, and medication administration. Items generally test the one step that invalidates the reading or wastes the dose.
Blood Pressure Monitors
Home and ambulatory measurement predicts cardiovascular outcomes better than office readings and identifies white coat and masked hypertension. Recommend a validated upper-arm oscillometric device ; wrist and finger devices are far more position-sensitive and are not recommended for routine diagnosis.
Cuff size is the most common source of error. The bladder should encircle at least 80% of the arm circumference and cover about 40% of the arm's length. A cuff that is too small overestimates blood pressure, potentially leading to unnecessary treatment; a cuff that is too large underestimates it.
Correct measurement technique:
No caffeine, smoking, or exercise for 30 minutes; empty the bladder.
Sit quietly for 5 minutes with the back supported and feet flat on the floor, legs uncrossed.
Bare the arm, support it at heart level , and do not talk during the measurement.
Take two readings one minute apart, morning and evening, and average them.
For a diagnostic home series, record for 7 consecutive days and discard day one.
Teach the patient to record readings or use the device memory, and to bring the monitor to the pharmacy periodically for comparison against a reference device.
Blood Glucose Meters and Continuous Glucose Monitoring
Meter selection considers dexterity and vision, sample volume, display size, memory, data connectivity, cost of strips (the true ongoing cost), and whether ketone testing is needed.
Technique points: wash and dry hands with warm water, or wipe away the first drop if washing is impossible, because residues such as fruit sugar cause falsely high readings. Use the sides of the fingertip , which are less densely innervated than the pulp, rotate sites, apply an adequate sample in one application, and check the strip expiry and, where the meter requires it, the lot code.
Interfering factors to teach: dehydration and extremes of temperature and altitude affect accuracy; high-dose acetaminophen and ascorbic acid interfere with some sensor chemistries.
Continuous glucose monitoring uses a subcutaneous sensor measuring interstitial glucose, which lags capillary glucose by roughly 5 to 15 minutes . Confirm with a fingerstick when symptoms do not match the sensor, during rapid change, or when treating hypoglycemia. Reports are interpreted as time in range, time below range, and glucose variability, which give far more information than an isolated glycated hemoglobin value.
Insulin Delivery
- Element Teaching point
- Pen needle A new needle for every injection ; reuse causes bent tips, painful injection, and dose inaccuracy
- Priming Prime 2 units and observe a droplet before every dose to clear air
Hold time Keep the needle in the skin for 5 to 6 seconds after the plunger bottoms out so the full dose is delivered
Site rotation Systematically rotate within a region; injecting repeatedly into one spot causes lipohypertrophy , which makes absorption erratic and unpredictable
Needle length 4 mm needles are appropriate for adults regardless of body size; no pinch-up is needed with 4 mm at 90 degrees
Storage Unopened vials and pens in the refrigerator; in-use pens at room temperature for the period specified for that product, and never frozen
Cloudy insulins Resuspend NPH and premixed insulins by gently rolling and inverting; do not shake
Examine injection sites at every review; palpable lipohypertrophy is common, easily missed, and a frequent explanation for unexplained glycemic variability.
Respiratory Devices
Peak flow meters are used for asthma self-monitoring. Technique: stand if possible, set the marker to zero, take a maximal breath in, seal the lips around the mouthpiece, and blow out as hard and fast as possible. Repeat three times and record the best value. Interpret against the patient's personal best , using zones — green above 80%, yellow 50 to 80%, red below 50% — written into an action plan.
Inhaler technique is reinforced at every encounter, since technique decays within weeks of teaching.
Device Essential step Frequent error
Pressurised metered-dose inhaler Slow deep inhalation while actuating, then hold breath 10 seconds Actuating before or after inhaling
Valved holding chamber One actuation, then breathe in slowly or take 5 tidal breaths Multiple actuations before inhaling
- Dry powder inhaler Forceful deep inhalation; keep dry Exhaling into the device and spoiling the dose
- Soft mist inhaler Prime before first use; slow steady inhalation Skipping the priming steps
A valved holding chamber should be recommended for children, older adults, and anyone with coordination difficulty. Wash it in warm soapy water, rinse, and air dry without towel drying , because rubbing generates static that traps drug on the walls. Nebulisers are reserved for patients who cannot use hand-held devices; clean and air dry the chamber after every use.
Other Devices
Thermometers. Digital axillary or oral for most; tympanic and temporal artery devices depend heavily on technique. Never use a rectal thermometer in a neutropenic patient , because of the risk of mucosal injury and bacteraemia.
Compression stockings. Correctly measured by ankle and calf circumference and by leg length, applied first thing in the morning before edema develops. Assess arterial supply first, since compression is contraindicated in significant peripheral arterial disease.
Spacers, eye drop aids, tablet splitters, and pill organisers support dexterity and vision limitations. Do not split or crush enteric-coated, modified-release, cytotoxic, or teratogenic products, and verify before recommending an organiser that every product is stable outside its original packaging.
Naloxone kits. Teach recognition of overdose, calling emergency services, administering intranasal or intramuscular naloxone, repeat dosing, and the need to stay because naloxone may wear off before the opioid does.